Imprimis Pharma (IMMY) Reports Q4 Loss of $0.30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to Imprimis Pharma (IMMY) Reports Q4 Loss of $0.30

Imprimis Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results and Provides Business Update

March 12, 2015 4:05 PM EDT

SAN DIEGO, March 12, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2014, and will provide an update on recent business developments on a conference call this afternoon.

Key 2014 and Recent Developments:

Launched our ophthalmology business in April 2014 with our Go Dropless educational campaign and flagship Dropless Therapy formulations for... More